Severe Legionnaires’ disease
Bedside summary
Pneumonia caused by Legionella pneumophila (waterborne; aerosol exposure). Although only ~5% of community-acquired pneumonia, it is a leading cause of CAP requiring ICU — roughly a third are admitted to intensive care and mortality reaches ~40% in ICU, immunocompromised or hospital-acquired cases. Suspect it in severe pneumonia with extrapulmonary clues.
Red flags
- Severe hypoxaemia / progression to ARDS
- Septic shock, multi-organ failure
- Immunocompromise or nosocomial acquisition (higher mortality)
- Rapidly extending consolidation
- Rhabdomyolysis / AKI
Assessment
Differential diagnosis
- Pneumococcal / other bacterial CAP
- Viral pneumonia (influenza, COVID-19)
- Other atypicals (Mycoplasma, Chlamydophila)
- Aspiration pneumonia
- ARDS from another cause
Investigations
- Legionella URINARY ANTIGEN (detects L. pneumophila serogroup 1) + lower-respiratory PCR/culture (detects all serogroups)
- CXR/CT (patchy → dense consolidation, may progress rapidly)
- FBC, U&E (HYPONATRAEMIA is a clue), LFTs (transaminitis), CRP/procalcitonin, CK (rhabdomyolysis), lactate, blood cultures
- ABG; assess for ARDS and organ failure
Management
- Assess severity (CURB-65 / sepsis) and resuscitate; high-flow oxygen; escalate early — severe LD deteriorates fast.
- Start EFFECTIVE ANTI-LEGIONELLA therapy promptly: a respiratory FLUOROQUINOLONE (levofloxacin or moxifloxacin) OR a macrolide (azithromycin).
- For SEVERE disease (ICU / immunocompromised): use COMBINATION therapy (a fluoroquinolone plus a macrolide, or plus rifampicin) and treat for a PROLONGED course — typically 7–10 days, extended (up to ~21 days) in the immunocompromised or slow responders.
- Full sepsis bundle: cultures, lactate, fluids, source consideration; supportive organ support.
- Lung-protective ventilation for ARDS; manage AKI, hyponatraemia, rhabdomyolysis and other organ dysfunction.
- Notify public health and investigate the water source (institutional outbreaks); review the empirical CAP regimen to ensure Legionella cover in severe cases.
Drugs & doses
Disposition
Complications & pitfalls
- ARDS and respiratory failure
- Septic shock, multi-organ failure
- AKI, rhabdomyolysis
- Hyponatraemia; hepatic dysfunction
- Death (up to ~40% in ICU cohorts)
Exam pearls
- Severe pneumonia + hyponatraemia + deranged LFTs + diarrhoea/confusion → think Legionella and send the urinary antigen.
- Empirical CAP cover for severe/ICU pneumonia must include an anti-Legionella agent.
- Urinary antigen catches only serogroup 1 — add lower-respiratory PCR/culture if suspicion is high.
- Severe cases need combination therapy and a longer course.
Suspect Legionella in severe CAP with extrapulmonary features; confirm with urinary antigen + respiratory PCR; treat promptly with a fluoroquinolone or macrolide — combination and prolonged therapy for severe/immunocompromised disease — alongside full sepsis and ARDS care.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.